Navigate Up

UPMC/University of Pittsburgh Schools of the Health Sciences

Senior Manager
Telephone: 412-578-9193 or 412-624-3212

Patients and medical professionals may call 1-800-533-UPMC (8762) for more information.
 

University of Pittsburgh Schools of the Health Sciences

Good Gene Hunting: University of Pittsburgh Researchers to Look for Genetic Influences on HDL Cholesterol

PITTSBURGH, April 11, 2007 The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has awarded a $2.9 million grant to researchers at the University of Pittsburgh's Graduate School of Public Health (GSPH) to uncover the genetic basis of high-density lipoprotein (HDL) cholesterol, the so-called good cholesterol, in African and U.S. white populations.

Higher levels of HDL have been shown to provide protection against the risk of coronary heart disease (CHD). Generally, African or African-derived populations have higher HDL levels than whites, which may ameliorate the risk of CHD among Africans. In Africa, CHD is near absent in rural areas, and very uncommon in urban centers.

According to principal investigator M. Ilyas Kamboh, Ph.D., professor and acting chair of the department of human genetics at GSPH, blood HDL cholesterol levels are determined both by environmental and genetic factors, with genes contributing more than 50 percent.

The task of identifying underlying genetic factors is not easy because there are multiple genes involved as well as interactions between genes and the environment. All of these have to be factored into studies to determine what contributes to variation in plasma HDL cholesterol levels between individuals and populations, Dr. Kamboh explained.

He said that most of the past efforts to identify genes for HDL cholesterol have been focused on screening for a few selected single nucleotide polymorphisms (SNPs) per each potential candidate gene, which is not optimal. However, the recent availability of high-throughput DNA sequencing technology has provided researchers the tools they need to build dense maps of markers for each gene being examined.

These maps, which we will make for each defined population in our study, will allow us to complete a much more thorough examination of the role of variation in genes that influence HDL cholesterol than we would by scanning for SNPs, said Dr. Kamboh.

In all, the four-year study will sequence more than 40 candidate genes from individuals who have extremely high or low HDL levels in order to find significant genetic variations. According to Dr. Kamboh, the successful completion of this study may lead to the identification of genetic variants that either decrease or increase the risk of CHD via HDL cholesterol in the general population, which could then become targets for drugs that can regulate these genes.

In addition to Dr. Kamboh, other GSPH researchers involved in the project include Yesim Demirci, M.D. and Candace Kammerer, Ph.D. of the department of human genetics and Clareann Bunker, Ph.D. of the department of epidemiology.

Founded in 1948 and fully accredited by the Council on Education for Public Health, GSPH is world-renowned for contributions that have influenced public health practices and medical care for millions of people. One of the top-ranked schools of public health in the United States, GSPH was the first fully accredited school of public health in the Commonwealth of Pennsylvania, with alumni who are among the leaders in their fields of public health. A member of the Association of Schools of Public Health, GSPH currently ranks third among schools of public health in National Institutes of Health funding received. The only school of public health in the nation with a chair in minority health, GSPH is a leader in research related to women's health, HIV/AIDS and human genetics, among others. For more information about GSPH, visit the schools Web site at http://www.publichealth.pitt.edu.

 

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com